SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Amgen Inc. (AMGN)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1906 112 0 AMGN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1206Rivals Laying Siege to Amgen's Near Monopoly in Anemia Drugs: investorshub.DewDiligence_on_SI-12/23/2005
1205Citigroup: AMGN: Updated Safety Labels for EPO Products a Non-Issue Decembermopgcw-12/11/2005
1204Seems to me that a stock split should be coming. As best I can recall, the compaJGoren-11/29/2005
1203<B>Idiopathic Pulmonary Fibrosis Has a Five-Year Survival Rate of 20%, AffJohn McCarthy-11/27/2005
1202TP Three or four weeks ago we were at 86 and change. AMGN will outperform a goSirWalterRalegh-11/17/2005
1201I'm not saying that AMGN is a mo-mo stock, but it takes some impressive lifttom pope-11/17/2005
1200[Denosumab (AMG 162) (ABGX): 2 year study results at ACR meeting] >>SAN Dtuck-11/14/2005
1199Data Show Aranesp(R) (Darbepoetin Alfa) Administered Once Monthly Maintains HeJohn McCarthy-11/12/2005
1198Nov 8th remarks by Roger Perlmutter UPDATE 1-Reuters Summit-Amgen confident of John McCarthy-11/8/2005
1197Message 21858295mopgcw-11/5/2005
1196AMGN (Amgen) forecast using Elliott Waves. Consider this forecast as an attempttrading_signal-10/30/2005
1195Nice post. Thank you. One problem: In Europe, as elsewhere, it's not neulsteve kammerer-10/28/2005
1194Legg: AMGN :Quarterly Sales Lighter Than Estimates But Improvement Is 2005-10-20mopgcw-10/28/2005
1193Motley Fool Amgen's Drive to Diversify Thursday October 20, 12:36 pm ET By mopgcw-10/21/2005
1192GS: AMGN(OP/N): Q3 sales light but fundamentals remain solid. Maintain yearly esmopgcw-10/20/2005
1191Amgen's Quarterly Net Soars On Strong Anemia Drug Sales By DAVID HAMILTON Doc Bones-10/20/2005
1190Amgen off some today on a Bear Sterns report that Roche has been issued a patenttuck-10/17/2005
1189citi/ssb q3 preview: For Amgen (AMGN), we expect continued solid product sales mopgcw-10/10/2005
1188GS: AMGN(OP/N): Beat Q2 on better sales, margins & taxes. Raise est. Rally mmopgcw-7/29/2005
1187GS: AMGN/DNA (OP/N): Meeting with Dr. McClellan, CMS Commissioner: Reimbursementmopgcw-7/29/2005
1186Looks like the wait was worthwhile. Excellent quarterly results with good conserSirWalterRalegh-7/19/2005
1185Barrons: Is Amgen or Genentech the Better Buy? By JOHANNA BENNETT NOW THE MOSTmopgcw-7/8/2005
1184LEGG MASON May 18, 2005 Amgen, Inc. NASDAQ:AMGN Updated Results From Panitumumopgcw-6/14/2005
1183Is anybody hearing any rumors? There's no news posted yet, but Amgen has beJGoren-5/10/2005
1182GS: AMGN(OP/N): Company visit confirmed positive view. Maintain estimates and Oumopgcw-5/2/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News